Stents should not precede optimal medical therapy in stable CAD
نویسندگان
چکیده
منابع مشابه
Percutaneous coronary intervention plus optimal medical therapy was not more effective than medical therapy alone in stable CAD.
M e t h o d s Design: Randomized controlled trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] trial). Allocation: Unclear allocation concealment.* Blinding: Blinded (outcome adjudication committee).* Follow-up period: Median 4.6 years (range 2.5 to 7.0 y). Setting: 50 centers in the United States and Canada. Patients: 2287 patients (mean age 62 y, 85%...
متن کاملComparison between Revascularization and Optimal Medical Therapy in Patients with Stable Angina Pectoris
Background and Purpose: Regarding usefulness of revascularization versus optimal medical therapy in patients with stable angina pectoris, data are challenging. The aim of this 12-month follow-up study was to compare the survival benefit associated with revascularization versus optimal medical therapy on the patients with stable angina pectoris. Materials and Methods: A prospective clinical s...
متن کاملPercutaneous coronary intervention with optimal medical therapy vs. optimal medical therapy alone for patients with stable angina pectoris
SCIENTIFIC BACKGROUND Stable Angina Pectoris (AP) is a main syndrome of chronic coronary artery disease (CAD), a disease with enormous epidemiological and health economic relevance. Medical therapy and percutaneous coronary interventions (PCI) are the most important methods used in the treatment of chronic CAD. RESEARCH QUESTIONS The evaluation addresses questions on medical efficacy, increme...
متن کاملcomparison between revascularization and optimal medical therapy in patients with stable angina pectoris
background and purpose: regarding usefulness of revascularization versus optimal medical therapy in patients with stable angina pectoris, data are challenging. the aim of this 12-month follow-up study was to compare the survival benefit associated with revascularization versus optimal medical therapy on the patients with stable angina pectoris. materials and methods: a prospective clinical stud...
متن کاملShould everolimus-eluting stents be preferred in patients with acute and stable coronary syndromes?
Drug-eluting stents (DES) were first approved in the United States in 2003 on the basis of improvement in angiographic and clinical restenosis. The first 2 DES, now referred to as “first-generation” DES, were the sirolimuseluting stent (SES) (Cypher, Cordis Corporation, Miami Lakes, Florida; approved in 2003) and paclitaxel-eluting stent (PES) (Taxus, Boston Scientific, Natick, Massachusetts; a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Cardiology
سال: 2012
ISSN: 1759-5002,1759-5010
DOI: 10.1038/nrcardio.2012.40